Expression of CD34 as a novel marker for glioneuronal lesions associated with chronic intractable epilepsy

Neuropathology and Applied Neurobiology

Volumn 32, Issue 5, 2006, Pages 461-468

  Deb, P ^a   Sharma, M C ^a   Tripathi, M ^a   Sarat Chandra, P ^a   Gupta, A ^a   Sarkar, C ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

CD34; DNT; Focal cortical dysplasia; Ganglioglioma; Immunohistochemistry; Intractable epilepsy

Indexed keywords

CD34 ANTIGEN; EOSIN; HEMATOXYLIN;

ADOLESCENT; ADULT; ANTIGEN EXPRESSION; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICAL DYSPLASIA; EVALUATION; FEMALE; GLIOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRACTABLE EPILEPSY; MALE; NEUROEPITHELIOMA; PRIORITY JOURNAL; STAINING;

ADOLESCENT; ADULT; ANTICONVULSANTS; ANTIGENS, CD34; BIOLOGICAL MARKERS; BRAIN NEOPLASMS; CEREBRAL CORTEX; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; DRUG RESISTANCE; EPILEPSY; FEMALE; GANGLIOGLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MIDDLE AGED; NEOPLASMS, NEUROEPITHELIAL; NEUROGLIA; NEURONS; TUMOR MARKERS, BIOLOGICAL;

EID: 33748752682     PISSN: 03051846     EISSN: 13652990     Source Type: Journal    
DOI: 10.1111/j.1365-2990.2006.00734.x     Document Type: Article

References (23)

1. Honavar M, Meldrum BS. Epilepsy. In Greenfield's Neuropathology, 7th edn. Eds DI Graham, PL Lantos. London: Arnold, 2002; 899-942
2. Pasquier B, Peoc'H M, Fabre-Bocquentin B, Bensaadi L, Pasquier D, Hoffmann D, Kahane P, Tassi L, Le Bas JF, Benabid AL. Surgical pathology of drug-resistant partial epilepsy. A 10-year-experience with a series of 327 consecutive resections. Epileptic Disord 2002; 4: 99-119
3. Blumcke I, Giencke K, Wardelmann E, Beyenburg S, Kral T, Sarioglu N, Pietsch T, Wolf HK, Schramm J, Elger CE, Wiestler OD. The CD34 epitope is expressed in neoplastic and malformative lesions associated with chronic, focal epilepsies. Acta Neuropathol (Berl) 1999; 97: 481-90
4. Wolf HK, Campos MG, Zentner J, Hufnagel A, Schramm J, Elger CE, Wiestler OD. Surgical pathology of temporal lobe epilepsy. Experience with 216 cases. J Neuropathol Exp Neurol 1993; 52: 499-506
5. Wolf HK, Wellmer J, Muller MB, Wiestler OD, Hufnagel A, Pietsch T. Glioneuronal malformative lesions and dysembryoplastic neuroepithelial tumors in patients with chronic pharmacoresistant epilepsies. J Neuropathol Exp Neurol 1995; 54: 245-54
6. Blumcke I, Wiestler OD. Gangliogliomas: an intriguing tumor entity associated with focal epilepsies. J Neuropathol Exp Neurol 2002; 61: 575-84
7. Blumcke I, Lobach M, Wolf HK, Wiestler OD. Evidence for developmental precursor lesions in epilepsy-associated glioneuronal tumors. Microsc Res Tech 1999; 46: 53-8
8. Miller CR, Perry A. CD34 and MAP2 immunohistochemistry in the differential diagnosis in the diagnosis of epilepsy associated glioneuronal tumors. Adv Anat Pathol 2004; 11: 326-7
9. Brown J, Greaves MF, Molgaard HV. The gene encoding the stem cell antigen, CD34, is conserved in mouse and expressed in haemopoietic progenitor cell lines, brain, and embryonic fibroblasts. Int Immunol 1991; 3: 175-84
10. Lin G, Finger E, Gutierrez-Ramos JC. Expression of CD34 in endothelial cells, hematopoietic progenitors and nervous cells in fetal and adult mouse tissues. Eur J Immunol 1995; 25: 1508-16
11. Miettinen M, Virolainen M, Maarit-Sarlomo-Rikala. Gastrointestinal stromal tumors - value of CD34 antigen in their identification and separation from true leiomyomas and schwannomas. Am J Surg Pathol 1995; 19: 207-16
12. van de Rijn M, Lombard CM, Rouse RV. Expression of CD34 by solitary fibrous tumors of the pleura, mediastinum, and lung. Am J Surg Pathol 1994; 18: 814-20
13. Park HR, Park YK. Assessment of diagnostic utility of anti-CD34 in soft tissue tumors. J Korean Med Sci 1995; 10: 436-41
14. Ogawa K, Tada T, Takahashi S, Sugiyama N, Inaguma S, Takahashi SS, Shirai T. Malignant solitary fibrous tumor of the meninges. Virchows Arch 2004; 444: 459-64
15. Baehring JM, Dickey PS, Bannykh SI. Epithelioid hemangioendothelioma of the suprasellar area: a case report and review of the literature. Arch Pathol Lab Med 2004; 128: 1289-93
16. Sutherland DR, Stewart AK, Keating A. CD34 antigen: molecular features and potential clinical applications. Stem Cells 1993; 11: 50-7
17. Asheuer M, Pflumio F, Benhamida S, Dubart-Kupperschmitt A, Fouquet F, Imai Y, Aubourg P, Cartier N. Human CD34+ cells differentiate into microglia and express recombinant therapeutic protein. Proc Natl Acad Sci USA 2004; 101: 3557-62
18. Palmini A, Najm I, Avanzini G, Babb T, Guerrini R, Foldvary-Schaefer N, Jackson G, Luders HO, Prayson R, Spreafico R, Vinters HV. Terminology and classification of the cortical dysplasias. Neurology 2004; 62: S2-8
19. Nelson JS, Bruner JM, Wiestler OD, Vandenburg SR. Ganglioglioma and gangliocytoma. In Pathology and Genetics of Tumors of the Nervous System. Eds P Kleihues, WK Cavenee. Lyon: IARC Press, 2000; 96-8
20. Daumas-Duport C, Pietsch T, Lantos PL. Dysembryoplastic neuroepithelial tumor. In Pathology and Genetics of Tumors of the Nervous System. Eds P Kleihues, WK Cavenee. Lyon: IARC Press, 2000; 103-4
21. Fauser S, Becker A, Schulze-Bonhage A, Hildebrandt M, Tuxhorn I, Pannek HW, Lahl R, Schramm J, Blumcke I. CD34-immunoreactive balloon cells in cortical malformations. Acta Neuropathol (Berl) 2004; 108: 272-8
22. Blumcke I, Becker AJ, Normann S, Hans V, Riederer BM, Krajewski S, Wiestler OD, Reifenberger G. Distinct expression pattern of microtubule- associated protein-2 in human oligodendrogliomas and glial precursor cells. J Neuropathol Exp Neurol 2001; 60: 984-93
23. Blumcke I, Muller S, Buslei R, Riederer BM, Wiestler OD. Microtubule-associated protein-2 immunoreactivity: a useful tool in the differential diagnosis of low-grade neuroepithelial tumors. Acta Neuropathol (Berl) 2004; 108: 89-96